IBDEI04C ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1690,1,4,0)
 ;;=4^438.41
 ;;^UTILITY(U,$J,358.3,1690,1,5,0)
 ;;=5^Late Effect CVA,Monopl,L/L,Dom Side
 ;;^UTILITY(U,$J,358.3,1690,2)
 ;;=^317917
 ;;^UTILITY(U,$J,358.3,1691,0)
 ;;=438.42^^11^140^8
 ;;^UTILITY(U,$J,358.3,1691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1691,1,4,0)
 ;;=4^438.42
 ;;^UTILITY(U,$J,358.3,1691,1,5,0)
 ;;=5^Late Effect CVA,Monopl,L/L,Non-Dom Side
 ;;^UTILITY(U,$J,358.3,1691,2)
 ;;=^317918
 ;;^UTILITY(U,$J,358.3,1692,0)
 ;;=438.84^^11^140^1
 ;;^UTILITY(U,$J,358.3,1692,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1692,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,1692,1,5,0)
 ;;=5^Ataxia
 ;;^UTILITY(U,$J,358.3,1692,2)
 ;;=^328507
 ;;^UTILITY(U,$J,358.3,1693,0)
 ;;=070.51^^11^141^1
 ;;^UTILITY(U,$J,358.3,1693,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1693,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,1693,1,5,0)
 ;;=5^Acute Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,1693,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,1694,0)
 ;;=070.54^^11^141^2
 ;;^UTILITY(U,$J,358.3,1694,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1694,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,1694,1,5,0)
 ;;=5^Chr Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,1694,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,1695,0)
 ;;=V02.62^^11^141^3
 ;;^UTILITY(U,$J,358.3,1695,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1695,1,4,0)
 ;;=4^V02.62
 ;;^UTILITY(U,$J,358.3,1695,1,5,0)
 ;;=5^Hepatitis C Carrier
 ;;^UTILITY(U,$J,358.3,1695,2)
 ;;=^317947
 ;;^UTILITY(U,$J,358.3,1696,0)
 ;;=300.00^^11^142^1
 ;;^UTILITY(U,$J,358.3,1696,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1696,1,4,0)
 ;;=4^300.00
 ;;^UTILITY(U,$J,358.3,1696,1,5,0)
 ;;=5^Anxiety NOS
 ;;^UTILITY(U,$J,358.3,1696,2)
 ;;=^9200
 ;;^UTILITY(U,$J,358.3,1697,0)
 ;;=295.90^^11^142^4
 ;;^UTILITY(U,$J,358.3,1697,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1697,1,4,0)
 ;;=4^295.90
 ;;^UTILITY(U,$J,358.3,1697,1,5,0)
 ;;=5^Schizophrenia NOS
 ;;^UTILITY(U,$J,358.3,1697,2)
 ;;=^108287
 ;;^UTILITY(U,$J,358.3,1698,0)
 ;;=296.20^^11^142^3
 ;;^UTILITY(U,$J,358.3,1698,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1698,1,4,0)
 ;;=4^296.20
 ;;^UTILITY(U,$J,358.3,1698,1,5,0)
 ;;=5^Depressive Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,1698,2)
 ;;=^303598
 ;;^UTILITY(U,$J,358.3,1699,0)
 ;;=296.7^^11^142^2
 ;;^UTILITY(U,$J,358.3,1699,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1699,1,4,0)
 ;;=4^296.7
 ;;^UTILITY(U,$J,358.3,1699,1,5,0)
 ;;=5^Bipolar I,Current NOS
 ;;^UTILITY(U,$J,358.3,1699,2)
 ;;=^331891
 ;;^UTILITY(U,$J,358.3,1700,0)
 ;;=344.1^^11^143^3
 ;;^UTILITY(U,$J,358.3,1700,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1700,1,4,0)
 ;;=4^344.1
 ;;^UTILITY(U,$J,358.3,1700,1,5,0)
 ;;=5^Paraplegia NOS
 ;;^UTILITY(U,$J,358.3,1700,2)
 ;;=^90028
 ;;^UTILITY(U,$J,358.3,1701,0)
 ;;=344.2^^11^143^1
 ;;^UTILITY(U,$J,358.3,1701,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1701,1,4,0)
 ;;=4^344.2
 ;;^UTILITY(U,$J,358.3,1701,1,5,0)
 ;;=5^Diplegia of Upper Limbs
 ;;^UTILITY(U,$J,358.3,1701,2)
 ;;=^268452
 ;;^UTILITY(U,$J,358.3,1702,0)
 ;;=344.9^^11^143^2
 ;;^UTILITY(U,$J,358.3,1702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1702,1,4,0)
 ;;=4^344.9
 ;;^UTILITY(U,$J,358.3,1702,1,5,0)
 ;;=5^Paralysis NOS
 ;;^UTILITY(U,$J,358.3,1702,2)
 ;;=^89838
 ;;^UTILITY(U,$J,358.3,1703,0)
 ;;=344.00^^11^143^9
 ;;^UTILITY(U,$J,358.3,1703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1703,1,4,0)
 ;;=4^344.00
 ;;^UTILITY(U,$J,358.3,1703,1,5,0)
 ;;=5^Quadriplegia,Unspec
 ;;^UTILITY(U,$J,358.3,1703,2)
 ;;=^101908
 ;;^UTILITY(U,$J,358.3,1704,0)
 ;;=344.01^^11^143^4
